Table 3.

Schizophrenia Hazard Ratio associated with Antibody Levels in Multiagent Models by Sex and Race^a

Factor	Hazard Ratiob	95% Confidence Interval	P Value
Men
HSV-1	1.03	0.90, 1.17	.71
HSV-2	0.97	0.84, 1.12	.63
CMV	0.90	0.78, 1.03	.12
EBV	0.92	0.81, 1.04	.17
VZV	0.99	0.87, 1.13	.91
HHV-6	1.17	1.03, 1.33	.01
Women
HSV-1	1.01	0.70, 1.47	.95
HSV-2	0.69	0.52, 0.92	.01
CMV	0.62	0.44, 0.89	.01
EBV	1.02	0.70, 1.48	.93
VZV	1.11	0.79, 1.57	.55
HHV-6	1.08	0.70, 1.66	.74
White
HSV-1	0.84	0.70, 1.01	.07
HSV-2	0.97	0.80, 1.19	.80
CMV	1.05	0.88, 1.25	.60
EBV	0.94	0.80, 1.11	.47
VZV	0.98	0.83, 1.16	.80
HHV-6	1.14	0.97, 1.33	.12
Black
HSV-1	1.23	1.02, 1.47	.03
HSV-2	0.83	0.70, 0.99	.03
CMV	0.69	0.57, 0.84	.00
EBV	0.95	0.79, 1.14	.56
VZV	1.09	0.92, 1.29	.31
HHV-6	1.17	0.97, 1.42	.10

Note: HSV-1, herpes simplex virus type 1; HSV-2, herpes simplex virus type 2; CMV, cytomegalovirus; EBV, Epstein-Barr virus; VZV, varicella-zoster virus; HHV-6, human herpes virus type 6.

^aAdjusted for age, hospitalization status, years of service, and temporal relationship to diagnosis.

^bHazard ratio expressed per 1 SD increase of each agent antibody level.